The pattern of multiple insider sales (4 in 30 days) at a pre-revenue biotech with strong analyst coverage is a cautionary signal. Monitor for additional Form 144 or Form 4 filings from other insiders.
Price Chart
Executive Summary
Gregory S. Moss, an officer of Evommune, filed a Form 144 on May 28, 2026, indicating intent to sell 14,223 shares of common stock valued at approximately $331,965. The shares were acquired through the exercise of stock options on the same day, and the sale is planned for the open market via Morgan Stanley. This insider sale follows three other insider sales totaling $871K over the past 30 days, creating a pattern of insider selling at a company with a $745M market cap and strong analyst consensus.
Key Facts
- Officer Gregory S. Moss filed Form 144 to sell 14,223 shares of common stock.
- Proposed sale value is approximately $331,965 based on filing date price.
- Shares were acquired via exercise of stock options on the same day (May 28, 2026).
- Sale is planned for open market execution through Morgan Stanley.
- This is the 4th insider sale in the last 30 days, totaling over $1.2M in proposed/actual insider selling.
- Company has a $745M market cap with 94% analyst bullish rating (16 Buy, 1 Hold).
Financial Impact
Proposed sale of $331,965 by an officer, representing approximately 0.04% of market cap.
Risk Factors
- Insider selling pattern may indicate lack of confidence ahead of clinical data readouts.
- Pre-revenue biotech with high cash burn — insider sales could signal concerns about runway or pipeline progress.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005228 |
| Document: 0001950047-26-005228-index.html | 0001950047-26-005228 |
| Document: 0001950047-26-005228.txt | 0001950047-26-005228 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 26d ago | 8-K | $7.21 | awaiting T+60 | — | $5.16 (−28.43%) |
Sep 15, 2026 6w ago | 8-K | $9.99 | awaiting T+60 | — | $5.16 (−48.35%) |
Jul 30, 2026 12w ago | 8-K | $11.35 $5.10 | ▼ −55.07% | ▼ −57.53% | $5.16 (−54.54%) |
Jul 10, 2026 15w ago | Insider Cluster | $12.10 $6.61 | ▼ −45.37% | ▼ −49.37% | $5.16 (−57.36%) |
Jun 29, 2026 17w ago | 8-K | $15.05 $9.60 | ▲ +36.21% | ▲ +40.60% | $5.16 (+65.71%) |
Jun 24, 2026 17w ago | Insider Cluster | $24.13 $9.65 | ▼ −60.01% | ▼ −63.74% | $5.16 (−78.62%) |
Jun 3, 2026 20w ago | Insider Cluster | $20.69 $13.23 | ▲ +36.06% | ▲ +37.94% | $5.16 (+75.06%) |
Jun 2, 2026 21w ago | 144 | $19.73 $13.48 | ▼ −31.68% | ▼ −34.18% | $5.16 (−73.85%) |
Jun 1, 2026 21w ago | Insider Cluster | $19.82 $14.11 | ▼ −28.81% | ▼ −29.93% | $5.16 (−73.97%) |
May 28, 2026 21w ago | 144 | $23.23 $13.67 | ▲ +41.15% | ▲ +42.34% | $5.16 (+77.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers